<DOC>
	<DOC>NCT02471859</DOC>
	<brief_summary>This is a Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending, Single- and Multiple-Oral Dose, Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Subjects.</brief_summary>
	<brief_title>A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Is male or female, using highly effective contraception Has a body mass index (BMI) 18.0 to 30.0 kg/m2, inclusive Is in good general health Having signed informed consent, is willing and able to comply with requirements of the study Does not satisfy all screening criteria per protocol Is employed by or related to any personnel involved in the trial Has any history or condition that per protocol or in the opinion of the investigator could compromise the participant's safety or analysis of results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>